23 web-programmer-developer "https:" "https:" "https:" "https:" uni jobs at VIB in Belgium
Sort by
Refine Your Search
-
Description We are seeking a motivated bioinformatics technician who wants to join the Guilliams and Scott labs with the VIB-Center for Inflammation Research. We have developed, and continue to
-
the successful delivery of genetically transformed plants for internal research and external stakeholders. In addition to transformation tasks, you will contribute to research and development aimed at improving
-
and business. VIB is committed to driving the growth of the life sciences cluster in Flanders. The VIB Technologies program is the institute's research infrastructure, offering access to cutting-edge
-
procedures and structured troubleshooting. Documentation & continuous improvement Develop and maintain documentation, including knowledge base articles, troubleshooting guides, and standard operating
-
, steering committees, status updates, escalation paths). Prepare concise, transparent status reporting for management and stakeholders. Ensure decisions are documented and communicated clearly across
-
with therapeutic innovation and biotech development. The ICT team of the VIB-UGent Center for Inflammation Research (IRC) in Zwijnaarde is looking for a motivated and service-oriented IT Helpdesk
-
Learning Expertise Unit at VIB.AI. Your role As an LLM Engineer, you will: Develop and deploy pilot projects in close collaboration with and tailored to VIB’s domain-specific centers, applying LLMs
-
learning support to the 15 Computational Biology cores and affiliated research groups at VIB.AI . Develop and deploy machine learning solutions for complex biological, biomedical, and biotechnological
-
. The link between basic research and valorisation has made VIB a catalyst for the ever-growing biotech hotspot in Flanders. VIB’s Innovation & Business (I&B) team consists of IP, business development, new
-
. The candidate will work in a team of scientists dedicated to develop antisense oligonucleotides as disease-modifying therapeutics for neurodegenerative diseases. Our strategy is based on an innovative, all-in